Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
New Hope for HIV Eradication
New Synthetic Proteins Block HIV
Additional Funding Awarded for Adherence Breathalyzer
A New Avenue Opens for Treating KS, CMV and Other Herpes Diseases
New Life for Treatment Interruptions?
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

June 19, 2009

Preterm Delivery, Low Birth Weight Unlikely with Perinatal HIV Treatment

HIV treatment does not increase the risk of preterm delivery, according to a French research analysis involving more than 8,000 HIV-negative babies born to HIV-positive women over a 16-year period. The new data, published June 19 in AIDS, dispel other reports suggesting that antiretroviral (ARV) therapy, notably protease inhibitors, affects fetal development and results in low birth weight.

Ever since short-term Retrovir (zidovudine) was proved to significantly reduce the risk of an HIV-infected mother passing on the virus to her child, there have been concerns about whether this ARV treatment could negatively affect the baby. Some studies have suggested that HIV drug regimens used during pregnancy, notably those including protease inhibitors, might increase the risk of premature births or babies born with lower-than-normal birth weight. Other studies, however, did not reach the same conclusions.

Nelly Briant, MD, from the Kremlin Bicêtre Hospital in Paris and her colleagues theorized the studies that did find an increased risk of preterm delivery were flawed in their design, failing to take into account certain risk factors known to be associated with preterm births, such as babies actually born with HIV infection, twins and infants born to mothers who injected drugs. In turn, her team conducted an additional analysis involving all live births to HIV-positive women participating in the French ANRS Perinatal Cohort between 1996 and 2000, after excluding babies born with HIV infection, twins and infants born to mothers who injected drugs.  

It turned out that babies born to women who used ARV therapy were no more likely to be delivered preterm or underweight compared with those born to women who did not use HIV treatment during pregnancy. The HIV-positive women were, however, about twice as likely to deliver low birth weight babies compared with women in the general population in France.

The authors acknowledge that their data may be difficult to generalize, as they did not collect information on alcohol use, smoking and economic status before 2005. Since all of these factors are associated with preterm deliveries and low birth weight, and were not factored into the analysis, it is not possible to say how they may have influenced the results of the study.

Search: pregnancy, child birth, low birth weight, preterm delivery, perinatal, HIV treatment


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy